Showing results (1401-1410 of 1,559) with videos related to

Sort By:
Pageof 156
American Journal of Veterinary Research|January 8, 2025
Chlamydial infections in free-ranging raptors presenting to a university veterinary medical teaching hospital (1993-2022)Michelle G Hawkins, Edith Blair, M Kevin Keel, et al.
Journal of Clinical Medicine|March 28, 2024
The Effect of Hydrostatic Pressure on Coronary Flow and Pressure-Based Indices of Coronary Stenosis SeverityFiras Al-Janabi, Grigoris V Karamasis, Christopher M Cook, et al.
Plos Genetics|December 4, 2009
Maize centromere structure and evolution: sequence analysis of centromeres 2 and 5 reveals dynamic Loci shaped primarily by retrotransposonsThomas K Wolfgruber, Anupma Sharma, Kevin L Schneider, et al.
Stem Cells Translational Medicine|March 15, 2015
Adipose-derived stem cells from diabetic mice show impaired vascular stabilization in a murine model of diabetic retinopathyStephen M Cronk, Molly R Kelly-Goss, H Clifton Ray, et al.
Investigative Ophthalmology & Visual Science|March 11, 2024
Isolation and Characterization of Extracellular Vesicles Through Orthogonal Approaches for the Development of Intraocular EV TherapyJustin Leung, Dimitrios Pollalis, Gopa K G Nair, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 7, 2026
Mirikizumab Long-Term Efficacy and Safety in Patients with Crohn's disease: Results from the VIVID-2 Open-Label Extension TrialBruce E Sands, Edward L Barnes, Geert D'Haens, et al.
Frontiers in Oncology|January 30, 2018
Pediatric Anaplastic Embryonal Rhabdomyosarcoma: Targeted Therapy Guided by Genetic Analysis and a Patient-Derived Xenograft StudyStuart L Cramer, Aubrey L Miller, Joseph G Pressey, et al.
Stem Cells Translational Medicine|August 26, 2015
Insulin-Producing Endocrine Cells Differentiated In Vitro From Human Embryonic Stem Cells Function in Macroencapsulation Devices In VivoAlan D Agulnick, Dana M Ambruzs, Mark A Moorman, et al.
Leukemia & Lymphoma|October 17, 2019
Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignanciesTanya Siddiqi, Paul Frankel, Jan H Beumer, et al.
The Lancet. Oncology|April 7, 2016
Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma: an open-label, dose-escalation, phase 1 trialAnas Younes, Jesus G Berdeja, Manish R Patel, et al.
Pageof 156